Please login to the form below

Not currently logged in
Email:
Password:

bribery

This page shows the latest bribery news and features for those working in and with pharma, biotech and healthcare.

US piles pressure on Mallinckrodt over alleged Acthar fraud

US piles pressure on Mallinckrodt over alleged Acthar fraud

$700m as a result of “eye-popping price increase” as well as “monopoly, bribery, racketeering, fraud and other deceptive and unfair practices”.

Latest news

More from news
Approximately 15 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    One of the most serious concerns is bribery, corruption and fraud, well-known problems in the country in recent times. ... So how does AZ ensure it doesn’t get entangled in bribery or corruption in China?

  • Risky business for pharma Risky business for pharma

    to consider, including but not limited to bribery and corruption, money laundering, competition and antitrust, cybersecurity, data privacy and regulation and compliance. ... posing the most significant risks overall”, perhaps due to continued

  • Stress testing for the perfect compliance storm Stress testing for the perfect compliance storm

    Yet the industry often hits the headlines for all the wrong reasons, with regulators imposing multibillion dollar settlements for compliance failings including corruption and bribery. ... However, EY’s Global Fraud Survey 2016 shows 11% of company

  • Harnessing commercial innovation Harnessing commercial innovation

    However, the situation in China was about to change significantly. Christian took up his China Region post in August 2013, when the full ramifications of the bribery scandal at GlaxoSmithKline had

  • The Heart of the Matter 5 - the only way is ethics The Heart of the Matter 5 - the only way is ethics

    The strengthening of international regulations around anti-bribery – and renewed vigour in their enforcement – has placed pharmaceutical companies under unparalleled scrutiny.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...